-
市场
-
产品
-
资讯
-
Moo社区
-
课堂
-
查看更多
-
功能介绍
-
费用费用透明,无最低余额限制
投资选择、功能介绍、费用相关信息由Moomoo Financial Inc.提供
- English
- 中文繁體
- 中文简体
- 深色
- 浅色
MMCAP International Inc. SPC Has $5.01 Million Position in Intelligent Medicine Acquisition Corp. (NASDAQ:IQMD)
MMCAP International Inc. SPC Has $5.01 Million Position in Intelligent Medicine Acquisition Corp. (NASDAQ:IQMD)
MMCAP International Inc. SPC reduced its holdings in Intelligent Medicine Acquisition Corp. (NASDAQ:IQMD – Get Rating) by 50.0% during the 2nd quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The firm owned 500,000 shares of the company's stock after selling 500,000 shares during the period. MMCAP International Inc. SPC's holdings in Intelligent Medicine Acquisition were worth $5,010,000 as of its most recent SEC filing.
Several other large investors have also bought and sold shares of IQMD. Basso Capital Management L.P. bought a new stake in Intelligent Medicine Acquisition in the first quarter valued at approximately $53,000. Woodline Partners LP bought a new stake in Intelligent Medicine Acquisition in the first quarter valued at approximately $250,000. Sona Asset Management US LLC bought a new stake in Intelligent Medicine Acquisition in the first quarter valued at approximately $299,000. Glazer Capital LLC bought a new stake in Intelligent Medicine Acquisition in the first quarter valued at approximately $311,000. Finally, DLD Asset Management LP bought a new stake in Intelligent Medicine Acquisition in the first quarter valued at approximately $432,000. 55.04% of the stock is currently owned by institutional investors and hedge funds.
Get Intelligent Medicine Acquisition alerts:Intelligent Medicine Acquisition Stock Up 0.1 %
NASDAQ:IQMD traded up $0.01 during trading hours on Friday, hitting $10.22. The stock had a trading volume of 17,727 shares, compared to its average volume of 29,087. Intelligent Medicine Acquisition Corp. has a one year low of $9.86 and a one year high of $10.93. The business's 50 day moving average is $10.12 and its 200-day moving average is $10.06.
About Intelligent Medicine Acquisition
(Get Rating)Intelligent Medicine Acquisition Corp. does not have significant operations. The company focuses on effecting a merger, capital stock exchange, asset acquisition, stock purchase, reorganization, or related business combination with one or more businesses. It intends to identify business opportunities in the field of life science.
See Also
- Get a free copy of the StockNews.com research report on Intelligent Medicine Acquisition (IQMD)
- Institutions Are Buying Ambarella, Should You?
- Can ZIM Defy Broad Downturn In The Container Shipping Industry?
- Ford Revving Up Production Of EV Power Units At U.K. Plant
- Are the Short Sellers Still Right About Mullen Automotive stock?
- La-Z-Boy Reclines To More Comfortable Levels
Want to see what other hedge funds are holding IQMD? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Intelligent Medicine Acquisition Corp. (NASDAQ:IQMD – Get Rating).
Receive News & Ratings for Intelligent Medicine Acquisition Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Intelligent Medicine Acquisition and related companies with MarketBeat.com's FREE daily email newsletter.
MMCAP International Inc. SPC reduced its holdings in Intelligent Medicine Acquisition Corp. (NASDAQ:IQMD – Get Rating) by 50.0% during the 2nd quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The firm owned 500,000 shares of the company's stock after selling 500,000 shares during the period. MMCAP International Inc. SPC's holdings in Intelligent Medicine Acquisition were worth $5,010,000 as of its most recent SEC filing.
根据纳斯达克向美国证券交易委员会(SEC)披露的最新信息,MMCAP国际公司在第二季度减持了智能药物收购公司(Sequoia Capital:IQMD-GET Rating)的股份50.0%。在此期间出售了50万股后,该公司持有50万股公司股票。截至最近提交给美国证券交易委员会的文件,MMPCAP International Inc.在智能医药收购中持有的股份价值5,010,000美元。
Several other large investors have also bought and sold shares of IQMD. Basso Capital Management L.P. bought a new stake in Intelligent Medicine Acquisition in the first quarter valued at approximately $53,000. Woodline Partners LP bought a new stake in Intelligent Medicine Acquisition in the first quarter valued at approximately $250,000. Sona Asset Management US LLC bought a new stake in Intelligent Medicine Acquisition in the first quarter valued at approximately $299,000. Glazer Capital LLC bought a new stake in Intelligent Medicine Acquisition in the first quarter valued at approximately $311,000. Finally, DLD Asset Management LP bought a new stake in Intelligent Medicine Acquisition in the first quarter valued at approximately $432,000. 55.04% of the stock is currently owned by institutional investors and hedge funds.
其他几家大型投资者也买卖了IQMD的股票。Basso Capital Management L.P.在第一季度购买了智能医疗收购的新股份,价值约53,000美元。Woodline Partners LP在第一季度购买了智能医疗收购的新股份,价值约25万美元。索纳资产管理美国有限责任公司在第一季度购买了智能医疗收购的新股份,价值约29.9万美元。Glazer Capital LLC在第一季度购买了智能医疗收购的新股份,价值约311,000美元。最后,DLD Asset Management LP在第一季度购买了智能医疗收购的新股份,价值约43.2万美元。55.04%的股票目前由机构投资者和对冲基金持有。
Intelligent Medicine Acquisition Stock Up 0.1 %
智能医药收购类股上涨0.1%
NASDAQ:IQMD traded up $0.01 during trading hours on Friday, hitting $10.22. The stock had a trading volume of 17,727 shares, compared to its average volume of 29,087. Intelligent Medicine Acquisition Corp. has a one year low of $9.86 and a one year high of $10.93. The business's 50 day moving average is $10.12 and its 200-day moving average is $10.06.
纳斯达克:iQMD在周五的交易时段上涨了0.01美元,达到10.22美元。该股成交量为17,727股,而其平均成交量为29,087股。智能医药收购公司的股价一年来最低为9.86美元,一年最高为10.93美元。该业务的50日移动均线切入位在10.12美元,200日移动均线切入位在10.06美元。
About Intelligent Medicine Acquisition
关于智能医疗采办
Intelligent Medicine Acquisition Corp. does not have significant operations. The company focuses on effecting a merger, capital stock exchange, asset acquisition, stock purchase, reorganization, or related business combination with one or more businesses. It intends to identify business opportunities in the field of life science.
智能医药收购公司没有重大业务。公司专注于与一家或多家企业进行合并、资本换股、资产收购、股票购买、重组或相关业务合并。它打算确定生命科学领域的商业机会。
See Also
另请参阅
- Get a free copy of the StockNews.com research report on Intelligent Medicine Acquisition (IQMD)
- Institutions Are Buying Ambarella, Should You?
- Can ZIM Defy Broad Downturn In The Container Shipping Industry?
- Ford Revving Up Production Of EV Power Units At U.K. Plant
- Are the Short Sellers Still Right About Mullen Automotive stock?
- La-Z-Boy Reclines To More Comfortable Levels
- 免费获取StockNews.com关于智能医学获取(IQMD)的研究报告
- 机构正在购买安巴雷拉,你应该吗?
- ZIM能否抵御集装箱航运业的普遍低迷?
- 福特在英国工厂加速生产电动汽车动力装置
- 卖空者对马伦汽车股票的看法仍然正确吗?
- La-Z-Boy倾斜到更舒适的水平
Want to see what other hedge funds are holding IQMD? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Intelligent Medicine Acquisition Corp. (NASDAQ:IQMD – Get Rating).
想看看还有哪些对冲基金持有IQMD吗?访问HoldingsChannel.com获取智能医药收购公司(纳斯达克代码:iqmd-Get Rating)的最新13F备案文件和内幕交易信息。
Receive News & Ratings for Intelligent Medicine Acquisition Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Intelligent Medicine Acquisition and related companies with MarketBeat.com's FREE daily email newsletter.
接受《智能医药采购日报》的新闻和评级-在下面输入您的电子邮件地址,通过MarketBeat.com的免费每日电子邮件时事通讯接收对智能医药收购和相关公司的最新新闻和分析师评级的每日简要摘要。
moomoo是Moomoo Technologies Inc.公司提供的金融信息和交易应用程序。
在美国,moomoo上的投资产品和服务由Moomoo Financial Inc.提供,一家受美国证券交易委员会(SEC)监管的持牌主体。 Moomoo Financial Inc.是金融业监管局(FINRA)和证券投资者保护公司(SIPC)的成员。
在新加坡,moomoo上的投资产品和服务是通过Moomoo Financial Singapore Pte. Ltd.提供,该公司受新加坡金融管理局(MAS)监管(牌照号码︰CMS101000) ,持有资本市场服务牌照 (CMS) ,持有财务顾问豁免(Exempt Financial Adviser)资质。本内容未经新加坡金融管理局的审查。
在澳大利亚,moomoo上的金融产品和服务是通过Futu Securities (Australia) Ltd提供,该公司是受澳大利亚证券和投资委员会(ASIC)监管的澳大利亚金融服务许可机构(AFSL No. 224663)。请阅读并理解我们的《金融服务指南》、《条款与条件》、《隐私政策》和其他披露文件,这些文件可在我们的网站 https://www.moomoo.com/au中获取。
在加拿大,通过moomoo应用提供的仅限订单执行的券商服务由Moomoo Financial Canada Inc.提供,并受加拿大投资监管机构(CIRO)监管。
在马来西亚,moomoo上的投资产品和服务是通过Moomoo Securities Malaysia Sdn. Bhd. 提供,该公司受马来西亚证券监督委员会(SC)监管(牌照号码︰eCMSL/A0397/2024) ,持有资本市场服务牌照 (CMSL) 。本内容未经马来西亚证券监督委员会的审查。
Moomoo Technologies Inc., Moomoo Financial Inc., Moomoo Financial Singapore Pte. Ltd., Futu Securities (Australia) Ltd, Moomoo Financial Canada Inc.,和Moomoo Securities Malaysia Sdn. Bhd.是关联公司。
风险及免责提示
moomoo是Moomoo Technologies Inc.公司提供的金融信息和交易应用程序。
在美国,moomoo上的投资产品和服务由Moomoo Financial Inc.提供,一家受美国证券交易委员会(SEC)监管的持牌主体。 Moomoo Financial Inc.是金融业监管局(FINRA)和证券投资者保护公司(SIPC)的成员。
在新加坡,moomoo上的投资产品和服务是通过Moomoo Financial Singapore Pte. Ltd.提供,该公司受新加坡金融管理局(MAS)监管(牌照号码︰CMS101000) ,持有资本市场服务牌照 (CMS) ,持有财务顾问豁免(Exempt Financial Adviser)资质。本内容未经新加坡金融管理局的审查。
在澳大利亚,moomoo上的金融产品和服务是通过Futu Securities (Australia) Ltd提供,该公司是受澳大利亚证券和投资委员会(ASIC)监管的澳大利亚金融服务许可机构(AFSL No. 224663)。请阅读并理解我们的《金融服务指南》、《条款与条件》、《隐私政策》和其他披露文件,这些文件可在我们的网站 https://www.moomoo.com/au中获取。
在加拿大,通过moomoo应用提供的仅限订单执行的券商服务由Moomoo Financial Canada Inc.提供,并受加拿大投资监管机构(CIRO)监管。
在马来西亚,moomoo上的投资产品和服务是通过Moomoo Securities Malaysia Sdn. Bhd. 提供,该公司受马来西亚证券监督委员会(SC)监管(牌照号码︰eCMSL/A0397/2024) ,持有资本市场服务牌照 (CMSL) 。本内容未经马来西亚证券监督委员会的审查。
Moomoo Technologies Inc., Moomoo Financial Inc., Moomoo Financial Singapore Pte. Ltd., Futu Securities (Australia) Ltd, Moomoo Financial Canada Inc.,和Moomoo Securities Malaysia Sdn. Bhd.是关联公司。
- 分享到weixin
- 分享到qq
- 分享到facebook
- 分享到twitter
- 分享到微博
- 粘贴板
使用浏览器的分享功能,分享给你的好友吧